Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

JNJ

Johnson&Johnson

NYSE

Real-time Quotes | Nasdaq Last Sale

171.62

+1.64

+0.96%

Opening 12:55 07/23 EDT

OPEN

170.87

PREV CLOSE

169.98

HIGH

171.90

LOW

170.38

VOLUME

2.36M

TURNOVER

52 WEEK HIGH

173.65

52 WEEK LOW

133.65

MARKET CAP

451.94B

P/E (TTM)

25.80

Analyzing Johnson & Johnson's Unusual Options Activity

On Friday, shares of Johnson & Johnson (NYSE:JNJ) saw unusual options activity. After the option alert, the stock price moved up to $171.59.

Benzinga · 6m ago

Medical chief says 83% of U.S. athletes at the Tokyo Olympics have been vaccinated

marketwatch.com · 38m ago

Stock Market Rally Rebounds To Highs; Snap, Crocs, Chipotle, Netflix Are Key Earnings

The market rally rebounded from Monday's lows, with the S&P 500 hitting a record high. Snap, Crocs and Chipotle were earnings winners.

Investor's Business Daily · 1h ago

This is the tipping point for when people vaccinated against COVID-19 should mask up again indoors

Masking is already being recommended again in parts of California. An infectious disease specialist weighs in.

MarketWatch · 1h ago

Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Johnson & Johnson (NYSE:JNJ) Investigation

NEW YORK, NY / ACCESSWIRE / July 23, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Johnson & Johnson ('J&J" or 'the Company') (NYSE:JNJ). Investors who purchased J&J shares are encouraged to obtain a...

ACCESSWIRE · 1h ago

U.S. not out of the woods with COVID cases rising in all 50 states, CDC head warns, urges unvaccinated to get their shots

marketwatch.com · 2h ago

'Don’t want to get vaccinated, leave' — hedge fund founder mandates Covid shots in his office

"If somebody wants to fight me over the vaccine mandate, that's fine. Let's take it to the court," SkyBridge's Anthony Scaramucci told CNBC on Friday.

CNBC.com · 3h ago

Johnson & Johnson's VERITAS Vision System available globally

Johnson & Johnson (JNJ) announces the global availability of the VERITAS Vision System, a phacoemulsification (phaco) system, for the treatment of cataracts.The company will offer live demos of the new system in a

Seekingalpha · 4h ago

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of JNJ. Analyze the recent business situations of Johnson&Johnson through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 21 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average JNJ stock price target is 187.53 with a high estimate of 203.00 and a low estimate of 160.00.

EPS

Institutional Holdings

Institutions: 3.97K

Institutional Holdings: 1.91B

% Owned: 72.48%

Shares Outstanding: 2.63B

TypeInstitutionsShares

Increased

1.59K

47.03M

New

142

2.50M

Decreased

1.18K

60.14M

Sold Out

2.30M

Performance
Asset Allocation
Dividend History

No Data

Industry

Pharmaceuticals

+0.78%

Pharmaceuticals & Medical Research

+0.65%

Key Executives

Chairman/Chief Executive Officer/Director

Alex Gorsky

Vice Chairman - Management/Chief Scientific Officer

Paulus Stoffels

Vice Chairman - Management

Joaquin Duato

Chief Financial Officer/Executive Vice President

Joseph Wolk

Chief Human Resource Officer/Executive Vice President

Peter Fasolo

Executive Vice President/General Counsel

Michael Ullmann

Executive Vice President

Ashley Mcevoy

Executive Vice President

Thibaut Mongon

Executive Vice President

Michael Sneed

Executive Vice President

Jennifer Taubert

Executive Vice President

Kathryn Wengel

Lead Director/Independent Director

Anne Mulcahy

Independent Director

Mary Beckerle

Independent Director

D. Scott Davis

Independent Director

Ian Davis

Independent Director

Jennifer Doudna

Independent Director

Marillyn Hewson

Independent Director

Hubert Joly

Independent Director

Mark Mcclellan

Independent Director

Charles Prince

Independent Director

A. Eugene Washington

Independent Director

Mark Weinberger

Independent Director

Nadja West

Independent Director

Ronald Williams

Declaration Date Dividend Per Share Ex-Div Date: 07/19/2021
Dividend USD 1.06
08/23/2021; 04/20/2021
Dividend USD 1.06
05/24/2021; 01/04/2021
Dividend USD 1.01
02/22/2021; 10/22/2020
Dividend USD 1.01
11/23/2020; 07/20/2020
Dividend USD 1.01
08/24/2020; 04/14/2020
Dividend USD 1.01
05/22/2020; 01/02/2020
Dividend USD 0.95
02/24/2020; 10/17/2019
Dividend USD 0.95
11/25/2019; 07/15/2019
Dividend USD 0.95
08/26/2019; 04/25/2019
Dividend USD 0.95
05/24/2019; 01/02/2019
Dividend USD 0.9
02/25/2019; 10/18/2018
Dividend USD 0.9
11/26/2018; 07/16/2018
Dividend USD 0.9
08/27/2018; 04/26/2018
Dividend USD 0.9
05/25/2018; 01/02/2018
Dividend USD 0.84
02/26/2018; 10/19/2017
Dividend USD 0.84
11/27/2017; 07/17/2017
Dividend USD 0.84
08/25/2017; 04/27/2017
Dividend USD 0.84
05/25/2017; 01/03/2017
Dividend USD 0.8
02/24/2017; 10/21/2016
Dividend USD 0.8
11/18/2016

All
Financials
Insiders

About JNJ

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Webull offers kinds of Johnson & Johnson stock information, including NYSE:JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.